A CCK(A)-receptor antagonist administered to the neonate alters mother- infant interactions in the rat

Aron Weller; Laura Dubson

doi:10.1016/S0091-3057(97)00530-3

A CCK(A)-receptor antagonist administered to the neonate alters mother- infant interactions in the rat

Aron Weller, Laura Dubson

Department of Psychology

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

The importance of the infants cholecystokinin (CCK) system for eliciting optimal maternal care was examined in 6 9-day-old Sprague Dawley rats. After administration of either vehicle. CCK-8 (1 or 8 μg/kg) or devazepide (1 mg/kg: a selective CCK(A) receptor antagonist), pups were either individually isolated (Experiment 1) or individually reunited with their dam (Experiment 2) and the rats behavior was observed. When isolated, pups that received devazepide displayed significantly more head-lifting anti wall-climbing attempts than vehicle-treated controls, suggesting that endogenous CCK dampens activity. Devazepide-treated rats were found more frequently in proximity with their mothers when reunited with them, and they emitted more ultrasonic vocalizations compared to vehicle controls. Pups treated with 1 μg/kg CCK received less body licking than vehicle controls. In addition dams hovered and crouched over devazepide-treated pups more than over pups treated with 1 μg/kg CCK. The results suggest that endogenous CCK his a calming quieting effect in the neonatal pup and that this, in turn, results in less infant-mother attractivity and reduced levels of maternal care.

Original language	English
Pages (from-to)	843-851
Number of pages	9
Journal	Pharmacology Biochemistry and Behavior
Volume	59
Issue number	4
DOIs	https://doi.org/10.1016/S0091-3057(97)00530-3
State	Published - Apr 1998

Bibliographical note

Funding Information:
The authors thank Dr. Elliott M. Blass for comments on a previous draft of the article, Iris Herman Gispan for performing Experiment 3, Aviram Rozin for his advice, and Ofra Schwartz for technical assistance. The authors are very grateful to Merck Co., West Point, PA, for the generous gift of devazepide. A portion of this research was part of an M.A. thesis in Psychology (L. D). Another portion of this research was supported by a grant from the Israel Science Foundation (A. W.)

Keywords

Cholecystokinin (CCK)
Devazepide
Infant-mother interactions
Maternal behaviour
Neonatal rats
Ultrasonic vocalization

Access to Document

10.1016/S0091-3057(97)00530-3

Cite this

@article{a11fc978662f4108b94bfc4e8bf3c3ce,

title = "A CCK(A)-receptor antagonist administered to the neonate alters mother- infant interactions in the rat",

abstract = "The importance of the infants cholecystokinin (CCK) system for eliciting optimal maternal care was examined in 6 9-day-old Sprague Dawley rats. After administration of either vehicle. CCK-8 (1 or 8 μg/kg) or devazepide (1 mg/kg: a selective CCK(A) receptor antagonist), pups were either individually isolated (Experiment 1) or individually reunited with their dam (Experiment 2) and the rats behavior was observed. When isolated, pups that received devazepide displayed significantly more head-lifting anti wall-climbing attempts than vehicle-treated controls, suggesting that endogenous CCK dampens activity. Devazepide-treated rats were found more frequently in proximity with their mothers when reunited with them, and they emitted more ultrasonic vocalizations compared to vehicle controls. Pups treated with 1 μg/kg CCK received less body licking than vehicle controls. In addition dams hovered and crouched over devazepide-treated pups more than over pups treated with 1 μg/kg CCK. The results suggest that endogenous CCK his a calming quieting effect in the neonatal pup and that this, in turn, results in less infant-mother attractivity and reduced levels of maternal care.",

keywords = "Cholecystokinin (CCK), Devazepide, Infant-mother interactions, Maternal behaviour, Neonatal rats, Ultrasonic vocalization",

author = "Aron Weller and Laura Dubson",

note = "Funding Information: The authors thank Dr. Elliott M. Blass for comments on a previous draft of the article, Iris Herman Gispan for performing Experiment 3, Aviram Rozin for his advice, and Ofra Schwartz for technical assistance. The authors are very grateful to Merck Co., West Point, PA, for the generous gift of devazepide. A portion of this research was part of an M.A. thesis in Psychology (L. D). Another portion of this research was supported by a grant from the Israel Science Foundation (A. W.) ",

year = "1998",

month = apr,

doi = "10.1016/S0091-3057(97)00530-3",

language = "אנגלית",

volume = "59",

pages = "843--851",

journal = "Pharmacology Biochemistry and Behavior",

issn = "0091-3057",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - A CCK(A)-receptor antagonist administered to the neonate alters mother- infant interactions in the rat

AU - Weller, Aron

AU - Dubson, Laura

N1 - Funding Information: The authors thank Dr. Elliott M. Blass for comments on a previous draft of the article, Iris Herman Gispan for performing Experiment 3, Aviram Rozin for his advice, and Ofra Schwartz for technical assistance. The authors are very grateful to Merck Co., West Point, PA, for the generous gift of devazepide. A portion of this research was part of an M.A. thesis in Psychology (L. D). Another portion of this research was supported by a grant from the Israel Science Foundation (A. W.)

PY - 1998/4

Y1 - 1998/4

N2 - The importance of the infants cholecystokinin (CCK) system for eliciting optimal maternal care was examined in 6 9-day-old Sprague Dawley rats. After administration of either vehicle. CCK-8 (1 or 8 μg/kg) or devazepide (1 mg/kg: a selective CCK(A) receptor antagonist), pups were either individually isolated (Experiment 1) or individually reunited with their dam (Experiment 2) and the rats behavior was observed. When isolated, pups that received devazepide displayed significantly more head-lifting anti wall-climbing attempts than vehicle-treated controls, suggesting that endogenous CCK dampens activity. Devazepide-treated rats were found more frequently in proximity with their mothers when reunited with them, and they emitted more ultrasonic vocalizations compared to vehicle controls. Pups treated with 1 μg/kg CCK received less body licking than vehicle controls. In addition dams hovered and crouched over devazepide-treated pups more than over pups treated with 1 μg/kg CCK. The results suggest that endogenous CCK his a calming quieting effect in the neonatal pup and that this, in turn, results in less infant-mother attractivity and reduced levels of maternal care.

AB - The importance of the infants cholecystokinin (CCK) system for eliciting optimal maternal care was examined in 6 9-day-old Sprague Dawley rats. After administration of either vehicle. CCK-8 (1 or 8 μg/kg) or devazepide (1 mg/kg: a selective CCK(A) receptor antagonist), pups were either individually isolated (Experiment 1) or individually reunited with their dam (Experiment 2) and the rats behavior was observed. When isolated, pups that received devazepide displayed significantly more head-lifting anti wall-climbing attempts than vehicle-treated controls, suggesting that endogenous CCK dampens activity. Devazepide-treated rats were found more frequently in proximity with their mothers when reunited with them, and they emitted more ultrasonic vocalizations compared to vehicle controls. Pups treated with 1 μg/kg CCK received less body licking than vehicle controls. In addition dams hovered and crouched over devazepide-treated pups more than over pups treated with 1 μg/kg CCK. The results suggest that endogenous CCK his a calming quieting effect in the neonatal pup and that this, in turn, results in less infant-mother attractivity and reduced levels of maternal care.

KW - Cholecystokinin (CCK)

KW - Devazepide

KW - Infant-mother interactions

KW - Maternal behaviour

KW - Neonatal rats

KW - Ultrasonic vocalization

UR - http://www.scopus.com/inward/record.url?scp=0031836217&partnerID=8YFLogxK

U2 - 10.1016/S0091-3057(97)00530-3

DO - 10.1016/S0091-3057(97)00530-3

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 9586840

AN - SCOPUS:0031836217

SN - 0091-3057

VL - 59

SP - 843

EP - 851

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

IS - 4

ER -

A CCK(A)-receptor antagonist administered to the neonate alters mother- infant interactions in the rat

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this